Skip to main content

Greenberg Traurig advises PlusDental shareholders on exit to medical devices company Straumann

Greenberg Traurig advised shareholders of health-tech start-up PlusDental on the sale to Straumann Group. The global manufacturer of dental replacement and orthodontic solutions has acquired 100 percent of the shares in Berlin-based PlusDental for a purchase price of approximately 135 million Swiss Francs. Merger clearance has been obtained, and the transaction has been completed.

PlusDental has branches in several European countries and is a leading provider of clear aligner treatments under close medical supervision. With additional market coverage in countries such as the Netherlands, Sweden and the UK, PlusDental expands the presence of Straumann Group in the medically supervised consumer orthodontics segment.

Background: Greenberg Traurig comprehensively advised shareholders of PlusDental consisting of strategic investors, private equity and venture capital investors as well as business angels on all legal aspects of the transaction. Cartel clearance was handled by special counsel.